|
1
|
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li
YJ, Yan B and Jiang Q: Pathogenic role of lncRNA-MALAT1 in
endothelial cell dysfunction in diabetes mellitus. Cell Death Dis.
5:e15062014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He JH, Zhang JZ, Han ZP, Wang L, Lv YB and
Li YG: Reciprocal regulation of PCGEM1 and miR-145 promote
proliferation of LNCaP prostate cancer cells. J Exp Clin Cancer
Res. 33:722014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xiang JF, Yin QF, Chen T, Zhang Y, Zhang
XO, Wu Z, Zhang S, Wang HB, Ge J, Lu X, et al: Human colorectal
cancer-specific CCAT1-L lncRNA regulates long-range chromatin
interactions at the MYC locus. Cell Res. 24:513–531. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jin M, Zhang T, Liu C, Badeaux MA, Liu B,
Liu R, Jeter C, Chen X, Vlassov AV and Tang DG: miRNA-128
suppresses prostate cancer by inhibiting BMI-1 to inhibit
tumor-initiating cells. Cancer Res. 74:4183–4195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rathod SS, Rani SB, Khan M, Muzumdar D and
Shiras A: Tumor suppressive miRNA-34a suppresses cell proliferation
and tumor growth of glioma stem cells by targeting Akt and Wnt
signaling pathways. FEBS Open Bio. 4:485–495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishihara T, Seki N, Inoguchi S, Yoshino H,
Tatarano S, Yamada Y, Itesako T, Goto Y, Nishikawa R, Nakagawa M
and Enokida H: Expression of the tumor suppressive miRNA-23b/27b
cluster is a good prognostic marker in clear cell renal cell
carcinoma. J Urol. 192:1822–1830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Z, Tang ZY, He Y, Liu LF, Li DJ and
Chen X: miRNA-205 is a candidate tumor suppressor that targets ZEB2
in renal cell carcinoma. Oncol Res Treat. 37:658–664. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Babae N, Bourajjaj M, Liu Y, Van Beijnum
JR, Cerisoli F, Scaria PV, Verheul M, Van Berkel MP, Pieters EH,
Van Haastert RJ, et al: Systemic miRNA-7 delivery inhibits tumor
angiogenesis and growth in murine xenograft glioblastoma.
Oncotarget. 5:6687–6700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jalali S, Bhartiya D, Lalwani MK,
Sivasubbu S and Scaria V: Systematic transcriptome wide analysis of
lncRNA-miRNA interactions. PLoS One. 8:e538232013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Augoff K, McCue B, Plow EF and
Sossey-Alaoui K: miR-31 and its host gene lncRNA LOC554202 are
regulated by promoter hypermethylation in triple-negative breast
cancer. Mol Cancer. 11:52012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang K, Sun T, Li N, Wang Y, Wang JX, Zhou
LY, Long B, Liu CY, Liu F and Li PF: MDRL lncRNA regulates the
processing of miR-484 primary transcript by targeting miR-361. PLoS
Genet. 10:e10044672014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Ying HQ, He BS, Pan YQ, Deng QW,
Sun HL, Chen J, Liu X and Wang SK: Upregulated lncRNA-UCA1
contributes to progression of hepatocellular carcinoma through
inhibition of miR-216b and activation of FGFR1/ERK signaling
pathway. Oncotarget. 6:7899–7917. 2015.PubMed/NCBI
|
|
14
|
Zhang R, Li M, Zang W, Chen X, Wang Y, Li
P, Du Y, Zhao G and Li L: MiR-148a regulates the growth and
apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2. Tumour
Biol. 35:837–844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang H, Li Y, Huang Q, Ren X, Hu H, Sheng
H and Lai M: MiR-148a promotes apoptosis by targeting Bcl-2 in
colorectal cancer. Cell Death Differ. 18:1702–1710. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lombard AP, Mooso BA, Libertini SJ, Lim
RM, Nakagawa RM, Vidallo KD, Costanzo NC, Ghosh PM and Mudryj M:
miR-148a dependent apoptosis of bladder cancer cells is mediated in
part by the epigenetic modifier DNMT1. Mol Carcinog. 55:757–767.
2016. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao S, Wen Z, Liu S, Liu Y, Li X, Ge Y
and Li S: MicroRNA-148a inhibits the proliferation and promotes the
paclitaxel-induced apoptosis of ovarian cancer cells by targeting
PDIA3. Mol Med Rep. 12:3923–3939. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu A, Xia J, Zuo J, Jin S, Zhou H, Yao L,
Huang H and Han Z: MicroRNA-148a is silenced by hypermethylation
and interacts with DNA methyltransferase 1 in gastric cancer. Med
Oncol. 29:2701–2709. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heo MJ, Kim YM, Koo JH, Yang YM, An J, Lee
SK, Lee SJ, Kim KM, Park JW and Kim SG: microRNA-148a dysregulation
discriminates poor prognosis of hepatocellular carcinoma in
association with USP4 overexpression. Oncotarget. 5:2792–2806.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Srikantan V, Zou Z, Petrovics G, Xu L,
Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino
K, et al: PCGEM1, a prostate-specific gene, is overexpressed in
prostate cancer. Proc Natl Acad Sci USA. 97:12216–12221. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Petrovics G, Zhang W, Makarem M, Street
JP, Connelly R, Sun L, Sesterhenn IA, Srikantan V, Moul JW and
Srivastava S: Elevated expression of PCGEM1, a prostate-specific
gene with cell growth-promoting function, is associated with
high-risk prostate cancer patients. Oncogene. 23:605–611. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fu X, Ravindranath L, Tran N, Petrovics G
and Srivastava S: Regulation of apoptosis by a prostate-specific
and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell
Biol. 25:135–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vargas MA, Tirnauer JS, Glidden N,
Kapiloff MS and Dodge-Kafka KL: Myocyte enhancer factor 2 (MEF2)
tethering to muscle selective A-kinase anchoring protein (mAKAP) is
necessary for myogenic differentiation. Cell Signal. 24:1496–1503.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pallavi SK, Ho DM, Hicks C, Miele L and
Artavanis-Tsakonas S: Notch and Mef2 synergize to promote
proliferation and metastasis through JNK signal activation in
Drosophila. EMBO J. 31:2895–2907. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Black BL, Molkentin JD and Olson EN:
Multiple roles for the MyoD basic region in transmission of
transcriptional activation signals and interaction with MEF2. Mol
Cell Biol. 18:69–77. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Coutinho-Camillo CM, Salaorni S, Sarkis AS
and Nagai MA: Differentially expressed genes in the prostate cancer
cell line LNCaP after exposure to androgen and anti-androgen.
Cancer Genet Cytogenet. 166:130–138. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Manteniotis S, Lehmann R, Flegel C, Vogel
F, Hofreuter A, Schreiner BS, Altmüller J, Becker C, Schöbel N,
Hatt H and Gisselmann G: Comprehensive RNA-Seq expression analysis
of sensory ganglia with a focus on ion channels and GPCRs in
Trigeminal ganglia. PLoS One. 8:e795232013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hanigan MH, Gallagher BC, Townsend DM and
Gabarra V: Gamma-glutamyl transpeptidase accelerates tumor growth
and increases the resistance of tumors to cisplatin in vivo.
Carcinogenesis. 20:553–559. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Daems C, Martin LJ, Brousseau C and
Tremblay JJ: MEF2 is restricted to the male gonad and regulates
expression of the orphan nuclear receptor NR4A1. Mol Endocrinol.
28:886–898. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tang QY and Feng MG: DPS Data Processing
System for Practical Statistics. Science Press; Beijing, China:
2002
|
|
32
|
Chang TH, Huang HY, Hsu JB, Weng SL, Horng
JT and Huang HD: An enhanced computational platform for
investigating the roles of regulatory RNA and for identifying
functional RNA motifs. BMC Bioinformatics. 14 Suppl 2:S42013.
|
|
33
|
Park JY, Lee JE, Park JB, Yoo H, Lee SH
and Kim JH: Roles of Long Non-Coding RNAs on Tumorigenesis and
Glioma Development. Brain Tumor Res Treat. 2:1–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang H, Wang Y, Ai M, Wang H, Duan Z,
Wang H, Zhao L, Yu J, Ding Y and Wang S: Long noncoding RNA CRNDE
stabilized by hnRNPUL2 accelerates cell proliferation and migration
in colorectal carcinoma via activating Ras/MAPK signaling pathways.
Cell Death Dis. 8:e28622017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang B, Luo T, Zhang M, Lu Z, Xue X and
Fang G: The novel long noncoding RNA RP11-357H14.17 acts as an
oncogene by promoting cell proliferation and invasion in
diffuse-type gastric cancer. Onco Targets Ther. 10:2635–2643. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen S, Shao C, Xu M, Ji J, Xie Y, Lei Y
and Wang X: Macrophage infiltration promotes invasiveness of breast
cancer cells via activating long non-coding RNA UCA1. Int J Clin
Exp Pathol. 8:9052–9061. 2015.PubMed/NCBI
|
|
37
|
Ho TT, Huang J, Zhou N, Zhang Z, Koirala
P, Zhou X, Wu F, Ding X and Mo YY: Regulation of PCGEM1 by p54/nrb
in prostate cancer. Sci Rep. 6:345292016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sacilotto N, Chouliaras KM, Nikitenko LL,
Lu YW, Fritzsche M, Wallace MD, Nornes S, García-Moreno F, Payne S,
Bridges E, et al: MEF2 transcription factors are key regulators of
sprouting angiogenesis. Genes Dev. 30:2297–2309. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schroeter A, Walzik S, Blechschmidt S,
Haufe V, Benndorf K and Zimmer T: Structure and function of splice
variants of the cardiac voltage-gated sodium channel Na(v)1.5. J
Mol Cell Cardiol. 49:16–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McKinsey TA, Zhang CL and Olson EN: MEF2:
A calcium-dependent regulator of cell division, differentiation and
death. Trends Biochem Sci. 27:40–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Laddha SV, Nayak S, Paul D, Reddy R,
Sharma C, Jha P, Hariharan M, Agrawal A, Chowdhury S, Sarkar C and
Mukhopadhyay A: Genome-wide analysis reveals downregulation of
miR-379/miR-656 cluster in human cancers. Biol Direct. 8:102013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fujita Y, Kojima K, Ohhashi R, Hamada N,
Nozawa Y, Kitamoto A, Sato A, Kondo S, Kojima T, Deguchi T and Ito
M: MiR-148a attenuates paclitaxel resistance of hormone-refractory,
drug-resistant prostate cancer PC3 cells by regulating MSK1
expression. J Biol Chem. 285:19076–19084. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chang TH, Huang HY, Hsu JB, Weng SL, Horng
JT and Huang HD: An enhanced computational platform for
investigating the roles of regulatory RNA and for identifying
functional RNA motifs. BMC bioinformatics. 14 Suppl 2:S42013.
|
|
44
|
Robinson JT, Thorvaldsdóttir H, Winckler
W, Guttman M, Lander ES, Getz G and Mesirov JP: Integrative
genomics viewer. Nat Biotechnol. 29:24–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Thorvaldsdóttir H, Robinson JT and Mesirov
JP: Integrative Genomics Viewer (IGV): High-performance genomics
data visualization and exploration. Brief Bioinform. 14:178–192.
2013. View Article : Google Scholar : PubMed/NCBI
|
